These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 7931338

  • 1. Neuroprotective effects of some monoamine oxidase-B inhibitors against DSP-4-induced noradrenaline depletion in the mouse hippocampus.
    Yu PH, Davis BA, Fang J, Boulton AA.
    J Neurochem; 1994 Nov; 63(5):1820-8. PubMed ID: 7931338
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical evidence of neuroprotection by R(-)-deprenyl and N-(2-hexyl)-N-methylpropargylamine on DSP-4-induced degeneration of rat brain noradrenergic axons and terminals.
    Zhang X, Zuo DM, Davis BA, Boulton AA, Yu PH.
    J Neurosci Res; 1996 Feb 15; 43(4):482-9. PubMed ID: 8699534
    [Abstract] [Full Text] [Related]

  • 3. Neurochemical and neuroprotective effects of some aliphatic propargylamines: new selective nonamphetamine-like monoamine oxidase B inhibitors.
    Yu PH, Davis BA, Durden DA, Barber A, Terleckyj I, Nicklas WG, Boulton AA.
    J Neurochem; 1994 Feb 15; 62(2):697-704. PubMed ID: 8294932
    [Abstract] [Full Text] [Related]

  • 4. Neuroprotection by R(-)-deprenyl and N-2-hexyl-N-methylpropargylamine on DSP-4, a neurotoxin, induced degeneration of noradrenergic neurons in the rat locus coeruleus.
    Zhang X, Zuo DM, Yu PH.
    Neurosci Lett; 1995 Feb 15; 186(1):45-8. PubMed ID: 7540268
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of MAO B, but not MAO A, blocks DSP-4 toxicity on central NE neurons.
    Gibson CJ.
    Eur J Pharmacol; 1987 Sep 02; 141(1):135-8. PubMed ID: 3117577
    [Abstract] [Full Text] [Related]

  • 6. Protection against DSP-4-induced neurotoxicity by deprenyl is not related to its inhibition of MAO B.
    Finnegan KT, Skratt JJ, Irwin I, DeLanney LE, Langston JW.
    Eur J Pharmacol; 1990 Aug 02; 184(1):119-26. PubMed ID: 2120076
    [Abstract] [Full Text] [Related]

  • 7. Neurochemical, neuroprotective and neurorescue effects of aliphatic N-methylpropargylamines; new MAO-B inhibitors without amphetamine-like properties.
    Yu PH, Davis BA, Zhang X, Zuo DM, Fang J, Lai CT, Li XM, Paterson IA, Boulton AA.
    Prog Brain Res; 1995 Aug 02; 106():113-21. PubMed ID: 8584647
    [Abstract] [Full Text] [Related]

  • 8. Neurotoxins and monoamine oxidase inhibition: new aspects.
    Finnegan KT.
    Mov Disord; 1993 Aug 02; 8 Suppl 1():S14-9. PubMed ID: 8302303
    [Abstract] [Full Text] [Related]

  • 9. Protective effect of 7-nitroindazole against DSP-4 induced noradrenaline depletion in mouse hippocampus.
    Szökõ E, Haberle D, Halász AS, Tekes K, Magyar K.
    J Neural Transm (Vienna); 2001 Aug 02; 108(4):407-13. PubMed ID: 11475008
    [Abstract] [Full Text] [Related]

  • 10. The effect of low oral doses of (-)-deprenyl and its metabolites on DSP-4 toxicity.
    Haberle D, Szökö E, Halász AS, Magyar K.
    J Neural Transm (Vienna); 2001 Aug 02; 108(11):1239-47. PubMed ID: 11768624
    [Abstract] [Full Text] [Related]

  • 11. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
    Karoum F.
    Br J Pharmacol; 1987 Feb 02; 90(2):335-45. PubMed ID: 3103805
    [Abstract] [Full Text] [Related]

  • 12. Determination of the norepinephrine level by high-performance liquid chromatography to assess the protective effect of MAO-B inhibitors against DSP-4 toxicity.
    Haberle D, Magyar K, Szöko E.
    J Chromatogr Sci; 2002 Oct 02; 40(9):495-9. PubMed ID: 12433110
    [Abstract] [Full Text] [Related]

  • 13. Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice.
    Fuller RW, Hemrick-Luecke SK, Kindt MV, Heikkila RE.
    Life Sci; 1988 Oct 02; 42(3):263-71. PubMed ID: 3121972
    [Abstract] [Full Text] [Related]

  • 14. Selective effects of DSP-4 on locus coeruleus axons: are there pharmacologically different types of noradrenergic axons in the central nervous system?
    Fritschy JM, Grzanna R.
    Prog Brain Res; 1991 Oct 02; 88():257-68. PubMed ID: 1726027
    [Abstract] [Full Text] [Related]

  • 15. Aliphatic propargylamines, a new series of potent selective, irreversible non-amphetamine-like MAO-B inhibitors. Their structures, function and pharmacological implications.
    Yu PH, Davis BA, Boulton AA.
    Adv Exp Med Biol; 1995 Oct 02; 363():17-23. PubMed ID: 7618520
    [Abstract] [Full Text] [Related]

  • 16. Depletion of NOS activity in the rat dentate gyrus neurons by DSP-4 and protection by deprenyl.
    Zhang X, Yu PH.
    Brain Res Bull; 1995 Oct 02; 38(4):307-11. PubMed ID: 8535851
    [Abstract] [Full Text] [Related]

  • 17. [A comparison of the pharmacology of (-)-deprenyl to N-methylpropargylamine-1-aminoindane (J-508) and rasagiline, the desmethyl-analogue of J-508].
    Miklya I.
    Neuropsychopharmacol Hung; 2008 Mar 02; 10(1):15-22. PubMed ID: 18771016
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological modifications of the neurotoxic action of the noradrenaline neurotoxin DSP4 on central noradrenaline neurons.
    Hallman H, Jonsson G.
    Eur J Pharmacol; 1984 Aug 17; 103(3-4):269-78. PubMed ID: 6237924
    [Abstract] [Full Text] [Related]

  • 19. [Effect of selegiline against selective neurotoxins].
    Magyar K.
    Vopr Med Khim; 1997 Aug 17; 43(6):504-14. PubMed ID: 9503567
    [Abstract] [Full Text] [Related]

  • 20. Identification of kaempferol as a monoamine oxidase inhibitor and potential Neuroprotectant in extracts of Ginkgo biloba leaves.
    Sloley BD, Urichuk LJ, Morley P, Durkin J, Shan JJ, Pang PK, Coutts RT.
    J Pharm Pharmacol; 2000 Apr 17; 52(4):451-9. PubMed ID: 10813558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.